Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms (NCT03728985)
🩺 Plain-English Summary (8th-Grade Level)
Prospective, non-randomized, , multicenter study with two independent arms: * Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System. Hypothesis-driven analysis. * Up to 65 additional subjects may be implanted in Continued Access Phase under the Primary Study Arm only * Secondary Study Arm - TAAA requiring TAMBE System and CTAG Device(s). Non hypothesis-driven analysis. Minimum: 122 implanted subjects. Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm)
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 19 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (44 Sites)
Showing the first 25 of 44 sites.
- University of Alabama at Birmingham — Birmingham, Alabama
- Mayo Clinic Arizona — Scottsdale, Arizona
- Keck Medical Center of USC — Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Kaiser Permanente San Francisco Medical Center — San Francisco, California
- Stanford University — Stanford, California
- MedStar Health Research Institute - MedStar Washington Hospital — Washington D.C., District of Columbia
- University of Florida - Gainesville — Gainesville, Florida
- University of South Florida — Tampa, Florida
- Emory University Hospital — Atlanta, Georgia
- Northwestern University — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- University of Maryland Medical Center — Baltimore, Maryland
- Massachusetts General Hospital — Boston, Massachusetts
- University of Michigan - Cardiac Surgery — Ann Arbor, Michigan
- Essentia Health — Duluth, Minnesota
- Division of Vascular Surgery - Minneapolis Heart Institute — Minneapolis, Minnesota
- Mayo Clinic - Rochester — Rochester, Minnesota
- Washington University School of Medicine — St Louis, Missouri
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
- Mount Sinai West — New York, New York
- Weill Cornell Medical Center — New York, New York
- University of Rochester — Rochester, New York
- University of North Carolina — Chapel Hill, North Carolina
- Sanger Heart & Vascular Institute — Charlotte, North Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Thoracoabdominal Aortic Aneurysm
- Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies — Los Angeles, California
- Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms — Boca Raton, Florida
- Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm — San Francisco, California
Explore by condition: All Thoracoabdominal Aortic Aneurysm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.